Clinical and Imaging Markers of Prodromal Parkinson's Disease
The diagnosis of Parkinson's disease (PD) relies on the clinical effects of dopamine deficiency, including bradykinesia, rigidity and tremor, usually manifesting asymmetrically. Misdiagnosis is common, due to overlap of symptoms with other neurodegenerative disorders such as multiple system atr...
Main Authors: | Eldbjørg Hustad, Jan O. Aasly |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2020-05-01
|
Series: | Frontiers in Neurology |
Subjects: | |
Online Access: | https://www.frontiersin.org/article/10.3389/fneur.2020.00395/full |
Similar Items
-
Increased Mortality in Young-Onset Parkinson’s Disease
by: Eldbjørg Hustad, et al.
Published: (2021-09-01) -
Sleep Spindles and Fragmented Sleep as Prodromal Markers in a Preclinical Model of LRRK2-G2019S Parkinson's Disease
by: Lindsey M. Crown, et al.
Published: (2020-05-01) -
CSF total and oligomeric α-Synuclein along with TNF-α as risk biomarkers for Parkinson’s disease: a study in LRRK2 mutation carriers
by: Nour K. Majbour, et al.
Published: (2020-05-01) -
Effects of dairy products intake on prodromal Parkinson's disease in Chinese adults aged 55 and above: A prospective cohort study
by: Siting ZHANG, et al.
Published: (2023-02-01) -
Prodromal Markers of Parkinson's Disease in Patients With Essential Tremor
by: Xi-Xi Wang, et al.
Published: (2020-08-01)